A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
|Slideshows|March 4, 2021
ECR 2021: Top Three Tips for Breast Imaging
Author(s)Whitney J. Palmer
Experts at ECR 2021 offer their top three tips for a variety of breast imaging techniques.
Advertisement
When it comes to breast imaging, there are many techniques and strategies available to pinpointing and assessing lesions. In a session during the 2021 European Congress of Radiology annual meeting, a group of international experts offered their top three tips for complex cystic and solid lesions, contrast-enhanced spectral mammography, stereotactic-guided biopsy, ultrasound-guided biopsy, and MRI-guided biopsy.
For additional ECR 2021 coverage, click
Take a quick look at the guidance they offered:
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter here .
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Catch up on the top radiology content of the past week.
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA
3
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
4
What’s Next for AI in Radiology?: Facilitating Data Orchestration Over Fragmentation
5